T1	Participants 84 143	men with signs and symptoms of benign prostatic hyperplasia
T2	Participants 813 884	923 patients (mean age 65 years) 466 received silodosin and 457 placebo
T3	Participants 372 576	Men 50 years or older with an International Prostate Symptom Score of 13 or greater and peak urinary flow rate of 4 to 15 ml per second received placebo or 8 mg silodosin daily with breakfast for 12 weeks
T4	Participants 2030 2101	Treatment with silodosin produced rapid improvement in urinary symptoms
